3 New Strong Buy Ratings from Top-Rated Analysts: 03/13/2026

By Jessie Moore, Stock Researcher and Writer
March 13, 2026 6:54 AM UTC
3 New Strong Buy Ratings from Top-Rated Analysts: 03/13/2026

Hello. These stocks are getting rave reviews from our Zen Ratings system:

  • AnaptysBio (ANAB) — FDA milestone could unlock 55% upside potential
  • Ross Stores (ROST) — Discount retailer expanding fast near 52-week highs
  • Broadcom (AVGO) — AI infrastructure giant trading 17% off its highs

P.S. Want more trending stocks? Check out this video on 4 stocks with massive upside potential right now.

 


A note from our sponsors...

Buffett's $114 Secret In 1943, a teenage Warren Buffett put $114 into a special type of account called "The 29% Account." Today, that single, $114 investment would be worth over $15 million. Your bank never told you about this. Click Here to See How It Works

1. Anaptysbio (NASDAQ: ANAB)

AnaptysBio is a clinical-stage biotech on the verge of a major catalyst — the FDA has accepted its application for imsidolimab in generalized pustular psoriasis, Q4 earnings beat estimates, and a strategic business separation is in the works to unlock even more value.

Zen Rating: Strong Buy (A)see full analysis

Recent Price: $62.10 — get current quote

Max 1-year forecast: $100.00

Why we're watching:

  • Analyst support: Strong consensus with 5 Strong Buy ratings and 2 Buy ratings among 7 analysts covering the stock. See the ratings
  • For example, Barclays researcher Etzer Darout (a top 2% rated analyst) recently maintained his Strong Buy rating with a $79 price target following positive momentum. An increase in market share is anticipated following new product launches with market entry planned for Q4.
  • Wells Fargo analyst Derek Archila (top 2%) also maintains a Strong Buy rating with an $81 price target.
  • Industry ranking context: ANAB is currently the 11th highest-rated stock in the Biotech industry, which has an Industry Rating of F.
  • Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr — this is a high conviction stock among the thousands of stocks we track. 
  • Component Grades: The company earns a B grade for Value and Financials, indicating solid fundamental strength despite operating in a challenging biotech sector with an F-rated industry backdrop. See all 7 Zen Component Grades here

2. Ross Stores (NASDAQ: ROST)

Ross Stores is doubling down on growth — with 17 new locations announced this month, the off-price retail giant behind Ross Dress for Less and dd's DISCOUNTS is riding a wave of momentum, and Wall Street analysts are upgrading the stock as confidence in its competitive edge grows.

Zen Rating: Buy (B) see full analysis

Recent Price: $211.75 — get current quote

Max 1-year forecast: $245.00

Why we're watching:

  • Analyst support: Strong Street backing with 8 Strong Buy ratings, 3 Buy ratings, and 2 Hold ratings among 13 analysts tracking the stock. See the ratings
  • Telsey Advisory Group's Dana Telsey (a top 3% rated analyst) recently upgraded Ross to Buy with a $240 price target, signaling increased conviction in the off-price retailer's trajectory.
  • Barclays analyst Adrienne Yih (top 4%) holds a Strong Buy rating with a $242 price target, representing 13.68% upside potential.
  • Industry ranking context: Ross ranks 3rd in the Apparel industry, which carries a strong A Industry Rating, positioning it among sector leaders.
  • Zen Rating highlights: Buy (B) stocks average +19.88%/yr, putting ROST in a class of stocks that have historically trounced the S&P.
  • Component Grades: Ross earns B grades for Sentiment, Safety, and Financials, with a solid 49.34% return on equity demonstrating efficient capital deployment and strong operational execution. See all 7 Zen Component Grades here

3. Broadcom (NASDAQ: AVGO)

Broadcom is trading nearly 18% off its highs — and that dip could be a gift. The semiconductor and software powerhouse just launched its first 400G/lane optical DSP for next-gen AI networks, cementing its role as a critical backbone of the AI infrastructure boom.

Zen Rating: Buy (B)see full analysis

Recent Price: $335.92 — get current quote

Max 1-year forecast: $582.00

Why we're watching:

  • Analyst support: Overwhelming bullish sentiment with 17 Strong Buy ratings, 5 Buy ratings, and just 2 Hold ratings among 24 analysts. See the ratings
  • Morgan Stanley's Joseph Moore (a top 1% rated analyst) recently maintained his Strong Buy rating with a $470 price target, citing robust earnings and strong growth forecasts with the company well-positioned to leverage market opportunities.
  • Truist Securities researcher William Stein (top 1%) holds the most bullish target at $545, representing 59.56% upside, expressing confidence in future profitability and sustained growth drivers with expansion to new sectors anticipated.
  • Citigroup analyst Atif Malik (top 1%) maintains a Strong Buy with a $475 target, noting Broadcom remains a critical player in the tech supply chain with substantial growth expected in earnings and revenue.
  • Nancy Pelosi is a notable AVGO investor — and in case you didn’t know, she’s got a GREAT track record. Check out more of her holdings here.
  • Industry ranking context: Broadcom ranks 5th in the Semiconductor industry, which has a B Industry Rating, positioning it among the elite in a high-growth sector.  
  • Zen Rating highlights: Buy (B) rated stocks average +19.88%/yr — AVGO could even exceed this. Why? Several positive signs, like the fact that analysts project 49.06% earnings growth compared to 34.84% for the semiconductor industry and 36.16% market-wide.
  • Component Grades: Broadcom ranks in the 80th percentile for Value, and the 85th percentile of stocks we track for Growth and Financials, demonstrating exceptional fundamental strength with 120.69% return on equity and 56.73% return on assets. See all 7 Zen Component Grades here

What to Do Next?

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.